Integridad Cientifica 2021
Integridad Cientifica 2021
Integridad Cientifica 2021
Abstract
Reproducibility and research integrity are essential tenets of every scientific study and discovery. They serve as proof
that an established and documented work can be verified, repeated, and reproduced. New knowledge in the bio‑
medical science is built on the shoulders of established and proven principles. Thus, scientists must be able to trust
and build on the knowledge of their colleagues. Scientific innovation and research discoveries especially in the field
of medicine has contributed to improving the lives of patients and increasing life expectancies. However, the growing
concerns of failure to comply with good scientific principles has resulted in issues with research integrity and repro‑
ducibility. Poor reproducibility and integrity, therefore, may lead to ineffective interventions and applications. Here we
comment on research reproducibility in basic medical and life sciences with regards to issues arising and outline the
role of stakeholders such as research institutions and their employees in addressing this crisis.
Keywords: Research integrity, Reproducibility, Research scientists, Research institutions, Stakeholders, Individual
contributions
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco
mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Diaba‑Nuhoho and Amponsah‑Offeh BMC Research Notes (2021) 14:451 Page 2 of 4
field, reproducibility can be described as taking an exist- research process, collaboration with multiple stakehold-
ing dataset from a study, re-running the same analysis ers such as academics, regulators, publishers, institu-
strategy that was used, and hopefully producing the exact tions, funders, and government are required to address
same statistical findings, this is usually useful for spot- the multifaceted reproducibility crisis. Moreover, the
ting errors. On the other hand, replication is utilising the recent pandemic has exposed these issues, which indeed
same or very similar methods as an existing study to col- should be the foundation of science. We outline some
lect new data, analysing it, and producing the same pat- suggestive remedies to this crisis by addressing the spe-
tern of results to draw the same overall conclusions [8]. cific role of researchers and institutions.
However, the last couple of decades have revealed shock- First-off, researchers should be more open to share
ingly the irreproducibility of several studies to validate ideas, methods and data with thematic colleagues and the
their major conclusions. This was further heightened by public. Researchers should devote more time for care-
the inability of original authors to reproduce their own ful planning, design and execution of scientific research
experiments [2]. The manifestation of the reproduc- including the use of appropriate experimental methods
ibility crisis became more visible in clinical trials by the and statistical analysis, which are necessary to arrive at a
increasing failure of novel treatment strategies, which good and a reproducible research outcome. Though most
were efficacious in diseased animal models [7]. A recent researchers would probably like to do these things, they
survey revealed that at least 70% of scientists were unable feel overburdened to the point that systemic pressures
to reproduce studies from other scientists as well as the and misplaced incentives prevent them from doing these
inability of at least 50% of researchers to reproduce their things. Research group leaders and supervisors must
own work [1]. The increasing concerns of this reproduc- provide adequate supervision, mentorship, and training
ibility crisis has triggered the implementation of policies to early career researchers to design good experiments
and guidelines to safeguard research credibility and trust- from the onset. All research authors must be able to
worthiness. Therefore, in order to provide solutions, it is provide the raw data used in their study and should be
important to identify the root causes of the crisis. made accessible to everyone without barriers. Possibly
setting up and making accessible data repositories for
Factors that influence the reproducibility crisis published papers will allow for transparency and integ-
The scientific research is a complex process involving rity in the research arena. Primary data is very crucial
several stakeholders at multiple steps such as research in research findings, hence avenues to store and avoid
design, ethics and legal framework, funding, methods, manipulation is essential. One way to ensure reproduc-
documentation, publication and archival of research ibility of results is to have a clear and concise documen-
findings. Moreover, many scientists and research hope to tation. This could be done electronically or manually as
reveal or identify novel findings and therapies [5]. Hence, in safe book-keeping of research data and findings which
multiple factors contribute to the irreproducibility of a are openly accessible. Documentation could include
study. These include but not limited to, inadequate train- open workflows, registered study protocols and meth-
ing of researchers in experimental design and methodol- odology. These are important since documentation can
ogy such as randomization, bias, replication, statistical be misrepresented if not accessible as part of shortcuts
analysis, variations in sophisticated medical techniques and poor research practices, thus maintaining the crisis.
that are difficult to replicate, and variability in chemicals Within research groups, group leaders or supervisors
and reagents especially in experiments involving the use must recheck storage of experimental results and when
of antibodies. Additionally, the insufficient amount of in doubt, experiments must be repeated by individuals
time used for research, the bureaucracy and pressure to or others in the laboratory to confirm breakthrough find-
publish in high impact journals to compete for research ings. For instance, in data analyses, at least two research-
grants and positions as well as lack of proper supervi- ers should be tasked to do same analyses. In ensuring the
sion and mentorship further exacerbates the reproduc- completeness of data in the context of publication, sci-
ibility crisis [1, 3]. These may lead to researchers taking entists and journal editors must ensure that data should
shortcuts, not transparently reporting their work, or even be contextualized instead of over generalized. Since good
using questionable research practices. data also depends on proper laboratory management,
established and standardized protocols as well as good
Addressing the reproducibility crisis and calibrated equipment with required standards must
Researchers are at the forefront of innovative findings. be routinely checked. With chemical analyses, standards
The same have being at the centre of recent scientific may be analysed together with the samples. By so doing
misconduct in different scientific fields [4]. Although errors could be detected and corrected. A periodic inter-
researchers and scientists play a dominant role in the laboratory analysis to compare results in case of doubts is
Diaba‑Nuhoho and Amponsah‑Offeh BMC Research Notes (2021) 14:451 Page 3 of 4
larly for early career researchers on the scientific research Standardised experimental methods
careers. Hence, training should be provided across board Tools/resources Open science Long-term funding
this crisis. This will require the participation and contri- 8. Tsang EWK, Kwan KM. Replication and theory development in
organizational science: a critical realist perspective. Acad Manag Rev.
bution of all, such as scientists, institutions, and different 1999;24(4):759–80. https://doi.org/10.2307/259353.
stakeholders to promote reproducibility and preserve the
integrity of research. Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
Acknowledgements
lished maps and institutional affiliations.
We are grateful to the editor and reviewers for their excellent comments,
which have substantially improved the quality of our manuscript. The authors
thank colleagues for their inputs and discussion on the topic.
Authors’ contributions
PDN and MAO wrote the paper. PDN and MA designed, compiled, and com‑
posed the original draft. PDN and MAO reviewed and revised the final draft.
Both authors read and approved the final manuscript.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Declarations
Ethics approval and consent to participate
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1
Division of Vascular Endothelium and Microcirculation, Department of Medi‑
cine III, University of Technology Dresden, Fetscherstr. 74, 01307 Dresden,
Germany. 2 Institute of Physiology, Faculty of Medicine, University of Technol‑
ogy Dresden, Fetscherstr. 74, 01307 Dresden, Germany.
References
1. Baker M. 1,500 scientists lift the lid on reproducibility. Nature.
2016;533(7604):452–4. https://doi.org/10.1038/533452a.
2. Begley CG, Ioannidis JP. Reproducibility in science: improving the
standard for basic and preclinical research. Circ Res. 2015;116(1):116–26.
https://doi.org/10.1161/CIRCRESAHA.114.303819.
3. Collins FS, Tabak LA. Policy: NIH plans to enhance reproducibility. Nature.
2014;505(7485):612–3. https://doi.org/10.1038/505612a.
4. Mebane CA, Sumpter JP, Fairbrother A, Augspurger TP, Canfield TJ, Good‑
fellow WL, Guiney PD, LeHuray A, Maltby L, Mayfield DB, McLaughlin MJ,
Ortego LS, Schlekat T, Scroggins RP, Verslycke TA. Scientific integrity issues
in Environmental Toxicology and Chemistry: improving research repro‑
Ready to submit your research ? Choose BMC and benefit from:
ducibility, credibility, and transparency. Integr Environ Assess Manag.
2019;15(3):320–44. https://doi.org/10.1002/ieam.4119.
• fast, convenient online submission
5. Munafo MR, Nosek BA, Bishop DVM, Button KS, Chambers CD, du Sert NP,
Simonsohn U, Wagenmakers EJ, Ware JJ, Ioannidis JPA. A manifesto for • thorough peer review by experienced researchers in your field
reproducible science. Nat Hum Behav. 2017;1(1): 0021. doi: https://doi. • rapid publication on acceptance
org/10.1038/s41562-016-0021
• support for research data, including large and complex data types
6. Steneck NH. Introduction to the responsible conduct of research. Wash‑
ington: US Government Printing Office; 2007. • gold Open Access which fosters wider collaboration and increased citations
7. Strech D, Weissgerber T, Dirnagl U, QUEST Group. Improving the trustwor‑ • maximum visibility for your research: over 100M website views per year
thiness, usefulness, and ethics of biomedical research through an innova‑
tive and comprehensive institutional initiative. PLoS Biol. 2020;18(2): At BMC, research is always in progress.
e3000576. https://doi.org/10.1371/journal.pbio.3000576.
Learn more biomedcentral.com/submissions